| ²é¿´: 554 | »Ø¸´: 6 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
evebľ³æ (ÕýʽдÊÖ)
|
[½»Á÷]
´ó¼Ò°ï濴һ϶þÉóÒâ¼û.¼¸¸öÒÉÎÊÇë¸ßÊÖÖ¸µã,лл
|
||
|
ÎÄÕ¾¹ý³õÉóÈôóÐÞ.´óÐÞºó¾¶þÉó,Òâ¼ûÈçÏ Reviewer #1: The paper has been clearly improved. However, the effects of bFGF gene silencing on glioma cell proliferation remain rather low. Minor point: the authors should label the x-axis of the diagram in Fig. 4. Reviewer #2: The authors have responded to most of the reviewers comments, but serious reservations remain. The biggest issue is that the effects observed are fairly modest, and do not provide convincing evidence that this approach will lead anywhere in glioma therapy. This could potentially be rescued by survival studies, or combinations with chemotherapeutics as suggested in the previous round of comments. The use of glioma stem-like cells may also help, as these may be more responsive to this approach. MINOR POINTS 1. the cell line should be referred to as LN229 rather than L229. 2. Exposure for the scratch assay shown in figure 2 is very uneven. ÏÖÓиöÒÉÎÊ.Çë¸ßÖ¸µãÒ»ÏÂÆÀÔÄÈ˵ÄÕ⼸¾ä»°ÓûشðÂð Reviewer #1: The paper has been clearly improved. However, the effects of bFGF gene silencing on glioma cell proliferation remain rather low. Reviewer #2: The authors have responded to most of the reviewers comments, but serious reservations remain. The biggest issue is that the effects observed are fairly modest, and do not provide convincing evidence that this approach will lead anywhere in glioma therapy. This could potentially be rescued by survival studies, or combinations with chemotherapeutics as suggested in the previous round of comments. The use of glioma stem-like cells may also help, as these may be more responsive to this approach. »¹ÊÇÖ»»Ø´ðÏÂÃæµÄ¼¸µã¾Í¿ÉÒÔ Minor point: the authors should label the x-axis of the diagram in Fig. 4. MINOR POINTS 1. the cell line should be referred to as LN229 rather than L229. 2. Exposure for the scratch assay shown in figure 2 is very uneven. ¸ßÊÖÖ¸µã.лл |
» ²ÂÄãϲ»¶
290Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
»¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô
ÒѾÓÐ32È˻ظ´
291 Çóµ÷¼Á
ÒѾÓÐ36È˻ظ´
ʳƷÓëÓªÑø£¨0955£©271Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
22408 312Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
һ־Ը³¶«´óѧ071000ÉúÎïѧѧ˶³õÊÔ·ÖÊý276Çóµ÷¼Á
ÒѾÓÐ26È˻ظ´
ҩѧÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð
ÒѾÓÐ39È˻ظ´
ÇóÖúµ÷¼Á£¬¿çµ÷
ÒѾÓÐ18È˻ظ´
08¹¤Ñ§ 309·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
weiswallow
Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 10 (Ó×¶ùÔ°)
- ½ð±Ò: 10678.1
- É¢½ð: 4
- ºì»¨: 4
- Ìû×Ó: 3936
- ÔÚÏß: 738.2Сʱ
- ³æºÅ: 600115
- ×¢²á: 2008-09-12
- רҵ: »¯Ñ§·´Ó¦¹¤³Ì
¡ï
eveb(½ð±Ò+1,VIP+0): 10-27 15:20
eveb(½ð±Ò+1,VIP+0): 10-27 15:20
| ²»¹ÜÊÇʲô£¬Ö»ÒªÊÇÉó¸åÒâ¼û£¬¶¼±ØÐëÒªÈÏÕæ»Ø´ðÓë½âÊÍ |

3Â¥2009-10-27 13:54:30
½ñÌìÀ´¹àË®
Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)
- Ó¦Öú: 110 (¸ßÖÐÉú)
- ¹ó±ö: 0.005
- ½ð±Ò: 8321.6
- É¢½ð: 947
- ºì»¨: 17
- Ìû×Ó: 4554
- ÔÚÏß: 745.7Сʱ
- ³æºÅ: 576005
- ×¢²á: 2008-06-19
2Â¥2009-10-27 12:07:45
liwenbin0929
гæ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 64.7
- Ìû×Ó: 314
- ÔÚÏß: 54·ÖÖÓ
- ³æºÅ: 870446
- ×¢²á: 2009-10-13
- רҵ: ¶¯ÎïÓªÑøÓëËÇÁÏ¿ÆÑ§
¡ï
eveb(½ð±Ò+1,VIP+0): 10-27 15:21
eveb(½ð±Ò+1,VIP+0): 10-27 15:21
| Â¥ÉÏÁ½Î»ËµµÄºÜ¶Ô£¬¶ÔÉó¸åÈËÌá³öµÄÒìÒ鱨Ðë×ö»Ø¸´£¬ÒªÐ޸ĵĵط½Ò²¿Ï¶¨ÊÇÒª¸ÄµÄ¡£Ì¬¶È¾ö¶¨Ò»ÇÐ |
4Â¥2009-10-27 13:59:05
realmadrider
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 6452.3
- Ìû×Ó: 1174
- ÔÚÏß: 167.9Сʱ
- ³æºÅ: 480981
- ×¢²á: 2007-12-17
- ÐÔ±ð: GG
- רҵ: ÎÞ»ú·Ç½ðÊôÀà¹âµçÐÅÏ¢Ó빦
¡ï
eveb(½ð±Ò+1,VIP+0): 10-27 15:21
eveb(½ð±Ò+1,VIP+0): 10-27 15:21
|
ÕâЩ¶¼ÊÇMINORµÄÎÊÌâ£¬Ç°ÃæµÄ²ÅÊÇMAJORµÄÎÊÌ⣬ºÃºÃ»Ø´ðÉó¸åÈ˵ÄÎÊÌâ |
5Â¥2009-10-27 14:22:44














»Ø¸´´ËÂ¥
20